South Korea · Biotechnology
Pharmaceuticals
Biotechnology
Healthcare
Theragen Etex group is a comprehensive pharmaceutical and biotechnology group providing outstanding genetic analysis services and progressing personalized new drug development. Theragen Bio specializes in genome analysis, NGS, and customized diagnostic solutions. Theragen Etex focuses on the production and supply of medicines, including orphan drug development and manufacturing of IMD. The company is recognized for its precision medicine capabilities and holds the world’s highest level of genome analysis technology.
2008
Founded
Biotechnology
Industry
South Korea
Location
52,567,323
Ranking
4 employees
Size

Get full access to view complete information

© Pubrio 2026